BIT — Biotron Income Statement
0.000.00%
Last trade - 00:00
- AU$67.65m
- AU$66.95m
- AU$1.43m
- 30
- 12
- 36
- 14
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.07 | 0.803 | 1.46 | 1.56 | 1.43 |
Cost of Revenue | |||||
Gross Profit | -0.043 | -2.05 | -1.67 | -1.26 | -1.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.77 | 4.44 | 4.67 | 4.34 | 5.04 |
Operating Profit | -1.7 | -3.64 | -3.2 | -2.78 | -3.61 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.61 | -3.58 | -3.19 | -2.78 | -3.49 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.61 | -3.58 | -3.19 | -2.78 | -3.49 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.61 | -3.58 | -3.19 | -2.78 | -3.49 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.61 | -3.58 | -3.19 | -2.78 | -3.49 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.003 | -0.005 | -0.004 | -0.004 | -0.004 |